{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/257079775",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1400950460"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#257079775",
  "code": "EH72.01",
  "source": "http://id.who.int/icd/entity/257079775",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/257079775/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/746448055",
        "http://id.who.int/icd/release/11/2024-01/mms/248569732",
        "http://id.who.int/icd/release/11/2024-01/mms/1530721759",
        "http://id.who.int/icd/release/11/2024-01/mms/817370856",
        "http://id.who.int/icd/release/11/2024-01/mms/1583926619"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Drug-induced anagen effluvium"
  },
  "definition": {
    "@language": "en",
    "@value": "Anagen effluvium due to medication, most commonly from cytotoxic cancer chemotherapy."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced anagen effluvium"
      }
    }
  ]
}